Wells Fargo & Company Cuts Bruker (NASDAQ:BRKR) Price Target to $60.00
Bruker (NASDAQ:BRKR – Free Report) had its target price decreased by Wells Fargo & Company from $75.00 to $60.00 in a report published on Thursday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the medical research company’s stock. A number of other brokerages have also recently weighed in on BRKR. Guggenheim reaffirmed […]
Bruker (NASDAQ:BRKR – Free Report) had its target price decreased by Wells Fargo & Company from $75.00 to $60.00 in a report published on Thursday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the medical research company’s stock. A number of other brokerages have also recently weighed in on BRKR. Guggenheim reaffirmed […]
